Skip to content

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00036348
Enrollment
Unknown
Registered
2002-05-10
Start date
2000-03-31
Completion date
2003-06-30
Last updated
2013-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar I disorder

Brief summary

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.

Interventions

DRUGAripiprazole

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.
Lead SponsorINDUSTRY

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with a history of Bipolar I Disorder

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026